MYASTHAENIA GRAVIS
Clinical trials for MYASTHAENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHAENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHAENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough mRNA therapy trial offers new hope for debilitating muscle disease
Disease control Recruiting nowThis study is testing an experimental mRNA CAR T-cell therapy called Descartes-08 in adults with generalized myasthenia gravis, a chronic autoimmune disease that causes severe muscle weakness. The goal is to see if this one-time cellular treatment can safely reduce symptoms and i…
Matched conditions: MYASTHAENIA GRAVIS
Phase: PHASE3 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
15-Year watch begins for patients who received experimental autoimmune therapy
Knowledge-focused Recruiting nowThis study is tracking the long-term safety and effects of an experimental cell therapy called KYV-101 in people who have already received it. Researchers will follow 70 participants for up to 15 years to check for any delayed side effects and see how long the treatment's effects…
Matched conditions: MYASTHAENIA GRAVIS
Sponsor: Kyverna Therapeutics • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC